I want to add the following. I'm an IT professional. In the course of my professional duties, I'm expected to…
Morning Headlines 11/1/13
Overrides of medication-related clinical decision support alerts in outpatients
A study published in JAMA looks at the value of clinical alerts within CPOE systems and finds that alerts are overridden 52 percent of the time. The most common alerts were duplicate drug (33.1%), patient allergy (16.8%), and drug–drug interactions (15.8%). The most likely alerts to be overridden were formulary substitutions, age-based recommendations, renal recommendations, and patient allergies.
Physician web portal and HIE vendor MEDSEEK acquires population health vendor SymphonyCare as part of a broader strategy to diversify its portfolio.
Merge Reports Third Quarter Financial Results
Merge reports Q3 results: revenue dropped to $57.7 million from $60.4 million during the same quarter last year, missing analysts estimates on both revenue and EPS.
WebMD buys startup Avado to connect patients and physicians
As part of a strategic makeover aimed at rebranding itself a patient engagement platform, WebMD acquires Avado, a startup that develops cloud-based software that helps physicians and patients interact online.
This paper is evidence that the CDS devices ought to be regulated for safety and efficacy by the FDA. Most of the drug interactions are nonsense, fifth order interactions.
What was omitted from the paper and what is omitted from CDS devices is that when certain medications are stopped, others increase or decrease in potency, and there is NO warning of that.
CDS devices fail to produce improved outcomes, wast professional time, and increase confusion. Moreover, they fail to warn when needed and fail to detect absurdity.